The PE Ratio as of September 2024 (TTM) for Cellectar Biosciences, Inc. (CLRB) is -0.67

According to Cellectar Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.67. This represents a change of -37.30% compared to the average of -1.07 of the last 4 quarters.

Cellectar Biosciences, Inc. (CLRB) Historical PE Ratio (quarterly & annually)

How has CLRB PE Ratio performed in the past?

The mean historical PE Ratio of Cellectar Biosciences, Inc. over the last ten years is -1.23. The current -0.67 PE Ratio has changed 5.34% with respect to the historical average. Over the past ten years (40 quarters), CLRB's PE Ratio was at its highest in in the December 2015 quarter at 1.67. The PE Ratio was at its lowest in in the September 2014 quarter at -5.50.

Cellectar Biosciences, Inc. (CLRB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cellectar Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cellectar Biosciences, Inc. (CLRB) Average PE Ratio

How has CLRB PE Ratio performed in the past?

The current PE Ratio of Cellectar Biosciences, Inc. (CLRB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cellectar Biosciences, Inc. (CLRB) PE Ratio vs. Peers

How is CLRB’s PE Ratio compared to its peers?

Cellectar Biosciences, Inc.’s PE Ratio is less than Diffusion Pharmaceuticals Inc. (0), less than Monopar Therapeutics Inc. (-0.00), greater than Pulmatrix, Inc. (-1.18), greater than Tenax Therapeutics, Inc. (-0.67), greater than Bio-Path Holdings, Inc. (-1.45), less than Catalyst Biosciences, Inc. (-0.14), less than Capricor Therapeutics, Inc. (-0.44), greater than NextCure, Inc. (-4.65), less than Longboard Pharmaceuticals, Inc. (-0.65), greater than Lumos Pharma, Inc. (-20.94), greater than ImmunoCellular Therapeutics, Ltd. (-0.86), less than Bolt Biotherapeutics, Inc. (0), less than Applied Molecular Transport Inc. (-0.37), less than Aileron Therapeutics, Inc. (-0.14), greater than Benitec Biopharma Inc. (-2.21), greater than null (-1.08),

Build a custom stock screener for Cellectar Biosciences, Inc. (CLRB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectar Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cellectar Biosciences, Inc. (CLRB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cellectar Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.